SLC12A6 Knockout HEK293 Cell Line
Cat.No.:
EDC07899
Species:
Human
Cell Name:
HEK293
Gene:
SLC12A6
Gene ID:
9990
Size:
1×10⁶cells
SLC12A6 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07899 |
|---|---|
| Product Name | SLC12A6 Knockout Cell Line(HEK 293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SLC12A6 |
| NCBI Gene ID | |
| Gene Synonyms | ACCPN|CMT2II|KCC3|KCC3A|KCC3B |
| Summary |
This gene is a member of the K-Cl cotransporter (KCC) family. K-Cl cotransporters are integral membrane proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The proteins encoded by this gene are activated by cell swelling induced by hypotonic conditions. Alternate splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are associated with agenesis of the corpus callosum with peripheral neuropathy. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC12A6 function, SLC12A6 Knockout HEK293 Cell Line or SLC12A6 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SLC12A6 (KCC3)'s role as a K⁺-Cl⁻ cotransporter or modeling Andermann syndrome (agenesis of corpus callosum with peripheral neuropathy). The Knockout line is the standard tool for asking whether KCC3 is required for K⁺-Cl⁻ efflux — KCC3 is broadly expressed and contributes to cell volume regulation, ion homeostasis, and neuronal chloride extrusion. Overexpression is useful for studying transport activity or for testing disease-associated mutations.
For KCC family research, the EDITGENE SLC12A6 Knockout in HEK293 is the standard mechanistic platform — HEK293 has been extensively used for KCC family biochemistry. SLC12A6 mutations cause Andermann syndrome (autosomal recessive ACCPN) — disease variant rescue enables genotype-function studies. Rescue with wild-type, transport-deficient, or phospho-mimetic (constitutively active, T991A/T1048A) KCC3 enables comprehensive structure-function and regulatory mechanism studies.
What are the application scenarios for this model?
Primary applications:
• K⁺-Cl⁻ cotransport: cellular K⁺ and Cl⁻ flux measurements using radiotracer or fluorescent probe-based assays.
• Cell volume regulation: regulatory volume decrease (RVD) assays following hypotonic challenge given KCC3's role in cell volume control.
• Andermann syndrome modeling: rescue with disease-associated SLC12A6 mutations for genotype-function correlation studies.
• Regulatory mechanism studies: WNK kinase-SPAK/OSR1 pathway analysis given KCC3 regulation through phosphorylation of conserved threonines (T991, T1048).
EDITGENE recommends this model for researchers investigating K⁺-Cl⁻ cotransport biology, cell volume regulation, and Andermann syndrome mechanisms.
Is this SLC12A6 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. KCC3 rescue experiments are well-established for cation-chloride cotransporter research:
• Construct design: use a codon-modified SLC12A6 sequence with a small C-terminal tag (FLAG, HA). KCC3 has 12 transmembrane domains with a large cytoplasmic C-terminus.
• Phospho-regulatory rescue: T991A/T1048A double mutation creates constitutively active KCC3, useful for distinguishing transport from regulatory effects.
• Andermann syndrome rescue: patient-derived SLC12A6 mutations enable disease genotype-function correlation.
• Functional readout: rescue should restore K⁺-Cl⁻ cotransport activity measured by ⁸⁶Rb⁺ flux or cell volume regulatory volume decrease.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download